Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of June 3, 2025 • 12:11 PM ET

Date/Time Source News Release
06/02/2025 06:59 AM EDT GlobeNewswire Aclaris Therapeutics Initiates Phase 2 Trial of Bosakitug (ATI-045) in Atopic Dermatitis
05/28/2025 09:20 AM EDT GlobeNewswire Aclaris Therapeutics to Participate in Two June Healthcare Conferences
05/09/2025 07:00 AM EDT GlobeNewswire Aclaris Therapeutics to Participate in the HC Wainwright "HCW@Home" Series
05/08/2025 06:50 AM EDT GlobeNewswire Aclaris Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update
04/29/2025 07:00 AM EDT GlobeNewswire Aclaris Therapeutics Appoints Jesse Hall, M.D. as Chief Medical Officer
04/22/2025 06:59 AM EDT GlobeNewswire Aclaris Therapeutics Secures U.S. Food and Drug Administration IND Clearance for ATI-052, Enabling Advancement of its Novel Bispecific Anti-TSLP/IL-4R Investigational Antibody
03/04/2025 07:00 AM EST GlobeNewswire Aclaris Therapeutics to Participate in Two March Healthcare Conferences
02/27/2025 06:59 AM EST GlobeNewswire Aclaris Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides a Corporate Update
02/12/2025 06:50 AM EST GlobeNewswire New Publication Highlights Unique Properties of ATI-2138, a Potent and Selective Inhibitor of ITK and JAK3
01/30/2025 04:01 PM EST GlobeNewswire Aclaris Therapeutics Announces Formation of New Scientific Advisory Board
Page

Additional News

As of June 3, 2025 • 12:11 PM ET

Date/Time Source News Release
05/08/2025 08:46 AM EDT SeekingAlpha Aclaris Therapeutics GAAP EPS of -$0.12, revenue of $1.46M
05/08/2025 08:00 AM EDT Zacks Aclaris Therapeutics (ACRS) Reports Q1 Loss, Misses Revenue Estimates
05/06/2025 07:00 AM EDT US Earnings Reports Expected US Company Earnings on Tuesday, May 6th, 2025
05/06/2025 05:31 AM EDT US Earnings Reports Expected earnings - Aclaris Therapeutics Inc.
04/22/2025 09:39 AM EDT SeekingAlpha Aclaris Therapeutics gets FDA nod to begin trial of ATI-052
02/27/2025 06:00 PM EST SeekingAlpha Aclaris Therapeutics plans $300M mixed shelf offering
02/27/2025 08:28 AM EST SeekingAlpha Aclaris Therapeutics GAAP EPS of -$1.01 misses by $0.78, revenue of $9.21M beats by $2.17M
02/27/2025 08:20 AM EST Zacks Aclaris Therapeutics (ACRS) Reports Q4 Loss, Tops Revenue Estimates
02/25/2025 06:00 AM EST US Earnings Reports Expected US Company Earnings on Tuesday, February 25th, 2025
02/25/2025 04:30 AM EST US Earnings Reports Expected earnings - Aclaris Therapeutics Inc.
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.